↓ Skip to main content

Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors

Overview of attention for article published in BMC Pharmacology, August 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
33 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Towards the development of novel Trypanosoma brucei RNA editing ligase 1 inhibitors
Published in
BMC Pharmacology, August 2011
DOI 10.1186/1471-2210-11-9
Pubmed ID
Authors

Jacob D Durrant, J Andrew McCammon

Abstract

Trypanosoma brucei (T. brucei) is an infectious agent for which drug development has been largely neglected. We here use a recently developed computer program called AutoGrow to add interacting molecular fragments to S5, a known inhibitor of the validated T. brucei drug target RNA editing ligase 1, in order to improve its predicted binding affinity.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 6%
Unknown 31 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 30%
Researcher 8 24%
Student > Bachelor 3 9%
Other 2 6%
Student > Postgraduate 2 6%
Other 6 18%
Unknown 2 6%
Readers by discipline Count As %
Chemistry 12 36%
Agricultural and Biological Sciences 11 33%
Biochemistry, Genetics and Molecular Biology 3 9%
Computer Science 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 6%
Unknown 2 6%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2011.
All research outputs
#20,145,561
of 22,651,245 outputs
Outputs from BMC Pharmacology
#60
of 63 outputs
Outputs of similar age
#114,037
of 124,309 outputs
Outputs of similar age from BMC Pharmacology
#5
of 6 outputs
Altmetric has tracked 22,651,245 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 63 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 124,309 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.